top of page
このホームページは
.com
を使って作成されました。あなたも無料で作ってみませんか？今すぐはじめる

Publications

​

 

  • 57. Stojak J, Morke C, Kuhn C, Blanquet V, Rocha D, Taniguchi H. Establishment of a cloning-free CRISPR/Cas9 protocol to generate large deletions in the bovine MDBK cell line. Journal of Applied Genetics. in press​

​​

  • 56. Łuczyńska K, Zhang Z, Pietras T, Zhang Y, Taniguchi H.NFE2L1/Nrf1 serves as a potential therapeutical target for neurodegenerative diseases. Redox Biol. 2023 69:103003. doi: 10.1016/j.redox.2023.103003.

​

  • 55. Taniguchi H. Liver Cancer 2.0. Int J Mol Sci . 2023 24(24):17275. doi: 10.3390/ijms242417275.

​

  • 54. Haque E, Teeli AS, Winiarczyk D, Taguchi M, Sakuraba S, Kono H, Leszczyński P, Pierzchała M, Taniguchi H. HNF1A POU Domain Mutations Found in Japanese Liver Cancer Patients Cause Downregulation of HNF4A Promoter Activity with Possible Disruption in Transcription Networks. Genes (Basel). 2022 13(3):413. doi: 10.3390/genes13030413.

​

  • 53.  Śmiech M, Leszczyński P, Wardell C, Poznański P, Pierzchała M, Taniguchi H. Oncogenic Mutation BRAF V600E Changes Phenotypic Behavior of THLE-2 Liver Cells through Alteration of Gene Expression. Int J Mol Sci. 2022 23(3):1548. doi: 10.3390/ijms23031548.

​

  • 52. Teeli AS, Łuczyńska K, Haque E, Gayas MA, Winiarczyk D, Taniguchi H. Disruption of Tumor Suppressors HNF4α/HNF1α Causes Tumorigenesis in Liver. Cancers (Basel). 2021 13(21):5357. doi: 10.3390/cancers13215357.

​

  • 51. Pierzchała D, Liput K, Korwin-Kossakowska A, Ogłuszka M, Poławska E, Nawrocka A, Urbański P, Ciepłoch A, Juszczuk-Kubiak E, Lepczyński A, Ślaska B, Kowal K, Te Pas MFW, Śmiech M, Leszczyński P, Taniguchi H, Fraser L, Sobiech P, Sachajko M, Herudzinska M, Pareek CS, Pierzchała M. Molecular Characterisation of Uterine Endometrial Proteins during Early Stages of Pregnancy in Pigs by MALDI TOF/TOF. Int J Mol Sci. 2021 22(13):6720. doi: 10.3390/ijms22136720.

​

  • 50. Haque E, Śmiech M, Łuczyńska K, Bouchard MF, Viger RS, Kono H, Pierzchala M, Taniguchi H. NRF2 DLG Domain Mutations Identified in Japanese Liver Cancer Patients Affect the Transcriptional Activity in HCC Cell Lines. Int J Mol Sci. 2021 22(10):5296. doi: 10.3390/ijms22105296.

​

  • 49. Harish V, Haque E, Śmiech M, Taniguchi H, Jamieson S, Tewari D, Bishayee A. Xanthohumol for Human Malignancies: Chemistry, Pharmacokinetics and Molecular Targets. Int J Mol Sci. 2021 Apr 25;22(9):4478. doi: 10.3390/ijms22094478.

​

  • 48. Leszczyński P, Śmiech M, Parvanov E, Watanabe C, Mizutani KI, Taniguchi H. Emerging Roles of PRDM Factors in Stem Cells and Neuronal System: Cofactor Dependent Regulation of PRDM3/16 and FOG1/2 (Novel PRDM Factors).Cells. 2020 Dec 4;9(12):2603. doi: 10.3390/cells9122603.

​

  • 47. Śmiech M, Leszczyński P, Kono H, Wardell C, Taniguchi H. Emerging BRAF Mutations in Cancer Progression and Their Possible Effects on Transcriptional Networks. Genes. 2020 11(11):E1342. doi: 10.3390/genes11111342.

​

  • 46. Leszczyński P, Śmiech M, Teeli AS, Haque E, Viger R, Ogawa H, Pierzchała M, Taniguchi H. Deletion of Prdm3 gene causes neuronal differentiation deficiency in P19 cells. Int J Mol Sci. 2020 29;21(19):7192. doi: 10.3390/ijms21197192.

 

  • 45. Haque E, Karim MR, Salam Teeli A, Śmiech M, Leszczynski P, Winiarczyk D, Parvanov ED, Atanasov AG, Taniguchi H. Molecular Mechanisms Underlying Hepatocellular Carcinoma Induction by Aberrant NRF2 Activation-Mediated Transcription Networks: Interaction of NRF2-KEAP1 Controls the Fate of Hepatocarcinogenesis. Int J Mol Sci. 2020 21(15):5378. doi: 10.3390/ijms21155378.

​

  • 44. Ishioka S, Hosokawa T, Ikeda T, Konuma N, Kaneda H, Ohashi K, Furuya T, Takayuki Masuko T, Taniguchi H, Kano K, Koshinaga T, Matsumoto T. Therapeutic potential of mature adipocyte-derived dedifferentiated fat cells for inflammatory bowel disease. Pediatric Surgery International. 2020 36(7):799-807. doi: 10.1007/s00383-020-04681-5.

 

  • 43. Shawon MAA, Yousuf MAK, Raheem E, Ahmed S, Dipti TT, Hoque MR, Taniguchi H, Karim MR. Epidemiology, clinical features, and impact of food habits on the risk of hepatocellular carcinoma: A case-control study in Bangladesh. Plos One. 2020 15(4):e0232121 doi: 10.1371/journal.pone.0232121. eCollection 2020.

 

  • 42. Smiech M, Leszczynski P, Haque E, Taniguchi H. Cloning free (DNA-free) CRISPR/Cas9-mediated gene knockout in human liver cell line and its detection. Chapter 10 of CRISPR-Cas Methods: Springer Protocols Handbooks CRISPR-Cas Methods. 2020 p163-171 ISBN 978-1-0716-0616-2.

 

  • 41. Teeli AS, Leszczynski P, Krishnaswamy N, Ogawa H, Tsuchiya M, Smiech M, Skarzynski DS, TaniguchiH. Possible mechanisms for maintenance and regression of corpus luteum through the ubiquitin-proteasome and autophagy system regulated by transcriptional factors. Front. Endocrinol. 2019 19;10:748. doi: 10.3389/fendo.2019.00748. eCollection 2019.

 

  • 40.  Yamazaki T, Kishimoto T, Leszczynski P, Sadakane K, Kenmotsu T, Watanabe H, Kazama T, Matsumoto T, Yoshikawa K, Taniguchi H. Construction of 3D Cellular Composites with Stem Cells Derived from Adipose Tissue and Endothelial Cells by Use of Optical Tweezers in a Natural Polymer Solution. Materials. 2019 12(11). pii: E1759. doi: 10.3390/ma12111759.

 

  • 39.  Bergeron F*, Sab AB*, Bouchard MF*, Taniguchi H, Souchkova O,  Brousseau C, Tremblay JJ, Pilon N, Viger RS. Phosphorylation of GATA4 serine 105 but not serine 261 is required for testosterone production in the male mouse. Andrology. 2019 (3):357-372. doi: 10.1111/andr.12601. *=contributed equally

 

  • 38. Leszczynski P, Smiech M, Teeli AS, Zołocinska A, Slysz A, Pojda Z, Pierzchała M, Taniguchi H. Neurogenesis using P19 Embryonal Carcinoma Cells. J Vis Exp.  2019 (146). doi: 10.3791/58225.

 

  • 37. Yamazaki T*, Taniguchi H*, Tsuji S, Sato S, KenmotsuT, Yoshikawa K, Sadakane K. Manipulating Living Cells to Construct Stable 3D Cellular Assembly Without Artificial Scaffold. J Vis Exp. 2018; (140). doi: 10.3791/57815 *=contributed equally

 

  • 36. Taniguchi H, Fujimoto A, Kono H, Furuta M, Fujita M, Nakagawa H.  Loss-of-function mutations in Zn-finger DNA-binding domain of HNF4A cause aberrant transcriptional regulation in liver cancer.  Oncotarget. 2018 9(40):26144-26156. doi: 10.18632/oncotarget.25456. eCollection 2018 May 25.

​

  • 35. #Haque E, #Taniguchi H, #Hassan MM, Karim MR, Bhowmik P, Smiech M, Zhao K, Rahman M and Islam T. Application of CRISPR/Cas9 genome editing technology for the improvement of crops cultivated in tropical climates: recent progress, prospects and challenges. Front. Plant Sci. 2018 9:617. doi: 10.3389/fpls.2018.00617. eCollection 2018.  #=contributed equally

 

  • 34. Shimizu M, Matsumoto T, Kikuta S, Ohtaki M, Kano K, Taniguchi H, Saito S, Nagaoka M, Tokuhashi Y. Transplantation of dedifferentiated fat cell-derived micromass pellets contributed to cartilage repair in the rat osteochondral defect model. J Orthop Sci. 2018 23:688-696. doi: 10.1016/j.jos.2018.03.001.

 

  • 33. Nishida Y, Iyadomi M, Tominaga H, Taniguch H, Higaki Y, Tanaka H, Otsubo H, Horita M, Hara M, Tanaka K. Influence of Single-Nucleotide Polymorphisms in PPAR-δ, PPAR-γ, and PRKAA2 on the Changes in Body Fat Indices and Blood Measures Through the Exercise-Centered Health Guidance in Japanese Middle-Aged Men. Int. J. Mol. Sci. 2018 19(3). pii: E703. doi: 10.3390 / ijms19030703. 

 

  • 32. Moosavi MA, Haghi A,  Rahmati M, Taniguchi H, Mocan A, Echeverría J, Gupta VK, Tzvetkov NT, Atanasov AG. Phytochemicals as potent modulators of autophagy for cancer therapy. Cancer letters. 2018 Feb 20. pii: S0304-3835 (18) 30163-0. doi: 10.1016 / j.canlet.2018.02.030.

 

  • 31. Khan H, Nabavi SM, Sureda A, Mehterov N, Gulei D, Neagoe IB, Taniguchi H, Atanasov AG. Therapeutic potential of songorine, a diterpenoid alkaloid of the genus Aconitum. European Journal of Medicinal Chemistry. 2017 Nov 10. pii: S0223-5234 (17) 30867-X. doi:10.1016 / j.ejmech.2017.10.065.

 

  • 30. Moore AW，Taniguchi H，Kamiguchi H. 2017 実験医学 A Japanese review 最強のステップUPシリーズ シングルセル解析による神経科学の新展開 p33-39; ISBN 978-4-7581-2234-4                                              

 

  • 29. Yoshida A*, Tsuji*, Taniguchi H*, Kenmotsu T, Sadakane K, Yoshikawa K. Manipulating living cells to construct a 3D single-cell assembly without an artificial scaffold. Polymers. 2017, 9, 319. doi:10.3390 / polym9080319 *= contributed equally

 

  • 28. Taniguchi H, Okamuro S, Kohji M, Waku T, Kubo K, Hatanaka A, Sun Y, Chowdhury AM, Fukamizu A, Kobayashi A. Possible roles of the transcription factor Nrf1 (NFE2L1) in neural homeostasis by regulating the gene expression of deubiquitinating enzymes. Biochem.Biophys.Res.Commun. 2017   Jan 11. pii: S0006-291X (17) 30047-5. doi: 10.1016 / j.bbrc.2017.01.038.

 

  • 27. Tsuchiya M, Karim MR, Matsumoto T, Ogawa H, Taniguchi H*. A protein preparation method for high-throughput identification of proteins interacting with a nuclear cofactor using LC-MS/MS analysis. J Vis Exp. 2017 Jan 24;(119). doi: 10.3791/55077. *corresponding

 

  • 26. Fukagai K, Waku T, Chowdhury AM, Kubo K, Matsumoto M, Kato H, Natsume T, Tsuruta F, Chiba T, Taniguchi H, Kobayashi A. USP15 stabilizes the transcription factor Nrf1 in the nucleus, promoting the proteasome gene expression. Biochem.Biophys.Res.Commun. 2016; 478: 363-370.

 

  • 25. Karim MR, Haruta T, Matsumoto T, Oda H, Taniguchi H*. Imaging of Cell Shape Alteration and Cell Movement in Drosophila Gastrulation Using DE-cadherin Reporter Transgenic Flies. J.Vis.Exp. 2016; (118). doi: 10.3791/54764. *corresponding

 

  • 24. Hashimoto S, Yoshida A, Ohta T, Taniguchi H, Sadakane K, Yoshikawa K. Formation of Stable Cell-Cell Contact without a Solid/Gel Scaffold: Non-invasive Manipulation by Laser under Depletion Interaction with a Polymer. Chemical Physics Letters. 2016;655-656:11–16.

 

  • 23. Fujimoto A, Okada Y, Boroevich KA, Tsunoda T, Taniguchi H, Nakagawa H. Systematic analysis of mutation distribution in three dimensional protein structures identifies cancer driver genes. Sci.Rep. 2016; 6: 26483.

 

  • 22. Fujimoto A*, Furuta M*, Totoki Y*, Tsunoda T*, Kato M*, Shiraishi Y, Tanaka H, Taniguchi H et al. Whole-genome mutational landscape and characterization of noncoding and structural mutations in liver cancer. Nat.Genet. 2016; 48: 500-509.* contributed equally.

 

  • 21.Taniguchi H, Kazama T, Hagikura K, Yamamoto C, Kazama M, Nagaoka Y, Matsumoto T. An Efficient Method to Obtain Dedifferentiated Fat Cells. J.Vis.Exp. 2016; (113). doi: 10.3791/54177.

 

  • 20. Tsuchiya M, Isogai S, Taniguchi H, Tochio H, Shirakawa M, Morohashi K, Hiraoka Y, Haraguchi T, Ogawa H. Selective autophagic receptor p62 regulates the abundance of transcriptional coregulator ARIP4 during nutrient starvation. Sci.Rep. 2015; 5: 14498.

​

  • 19. Karim MR, Taniguchi H, Kobayashi A. Constitutive activation of Drosophila CncC transcription factor reduces lipid formation in the fat body. Biochem.Biophys.Res.Commun. 2015; 463: 693-698.

 

  • 18. Nakagawa H, Wardell CP, Furuta M, Taniguchi H, Fujimoto A. Cancer whole-genome sequencing: present and future. Oncogene. 2015; 34: 5943-5950.

 

  • 17. Ito T, Taniguchi H, Fukagai K, Okamuro S, Kobayashi A. Inhibitory mechanism of FAT4 gene expression in response to actin dynamics during Src-induced carcinogenesis. PLoS One. 2015; 10: e0118336.

 

  • 16. Taniguchi H, Moore AW. Chromatin regulators in neurodevelopment and disease: Analysis of fly neural circuits provides insights: Networks of chromatin regulators and transcription factors underlie Drosophila neurogenesis and cognitive defects in intellectual disability and neuropsychiatric disorder  models. Bioessays. 2014; 36: 872-883.

 

  • 15. Karim MR, Endo K, Moore AW, Taniguchi H. Whole mount immunolabeling of olfactory receptor neurons in the Drosophila antenna. J.Vis.Exp. 2014; (87). doi: 10.3791/51245.

 

  • 14. Tsuchiya Y, Taniguchi H, Ito Y, Morita T, Karim MR, Ohtake N, Fukagai K, Ito T, Okamuro S, Iemura S, Natsume T, Nishida E, Kobayashi A. The casein kinase 2-nrf1 axis controls the clearance of ubiquitinated proteins by regulating proteasome gene expression. Mol.Cell.Biol. 2013; 33: 3461-3472.

 

  • 13. Endo K, Taniguchi H*, Karim MR*, Krejci A, Kinameri E, Siebert M, Ito K, Bray SJ, Moore AW. Chromatin modification of Notch targets in olfactory receptor neuron diversification. Nat.Neurosci. 2012; 15: 224-233. *contributed equally (Recommended by Faculty of 1000 Biology), introduced by Sci. Signal. 5 (210), ec43. and Nat Neurosci.2012 15:174-6.

 

  • 12. Krishnaswamy N, Lacroix-Pepin N, Chapdelaine P, Taniguchi H, Kauffenstein G, Chakravarti A, Danyod G, Fortier MA. Epidermal growth factor receptor is an obligatory intermediate for oxytocin-induced cyclooxygenase 2 expression and prostaglandin F2 alpha production in bovine endometrial epithelial cells. Endocrinology. 2010; 151: 1367-1374.

 

  • 11. Taniguchi H, Komiyama J, Viger RS, Okuda K. The expression of the nuclear receptors NR5A1 and NR5A2 and transcription factor GATA6 correlates with steroidogenic gene expression in the bovine corpus luteum. Mol.Reprod.Dev. 2009; 76: 873-880. 

 

  • 10. Taniguchi H*, Bouchard MF*, Viger RS. The effect of human GATA4 gene mutations on the activity of target gonadal promoters. J.Mol.Endocrinol. 2009; 42: 149-160. *contributed equally

 

  • 9. Taniguchi H*, Miyamoto Y*, Hamel F, Silversides DW, Viger RS. A GATA4/WT1 cooperation regulates transcription of genes required for mammalian sex determination and differentiation. BMC Mol.Biol. 2008; 9: 44-2199-9-44. *contributed equally

 

  • 8. Robert NM*, Miyamoto Y*, Taniguchi H, Viger RS. LRH-1/NR5A2 cooperates with GATA factors to regulate inhibin alpha-subunit promoter activity. Mol.Cell.Endocrinol. 2006; 257-258: 65-74.*contributed equally

 

  • 7. Bouchard MF, Taniguchi H, Viger RS. Protein kinase A-dependent synergism between GATA factors and the nuclear receptor, liver receptor homolog-1, regulates human aromatase (CYP19) PII promoter activity in breast cancer cells. Endocrinology. 2005; 146: 4905-4916 (Recommended by Faculty of 1000 Biology).

 

  • 6. Taniguchi H*, Martin LJ*, Robert NM, Simard J, Tremblay JJ, Viger RS. GATA factors and the nuclear receptors, steroidogenic factor 1/liver receptor homolog 1, are key mutual partners in the regulation of the human 3beta-hydroxysteroid dehydrogenase type 2 promoter. Mol.Endocrinol. 2005; 19: 2358-2370.*contributed equally

 

  • 5. Viger RS, Taniguchi H, Robert NM, Tremblay JJ. Role of the GATA family of transcription factors in andrology. J.Androl. 2004; 25: 441-452.

 

  • 4. Taniguchi H, Yokomizo Y, Okuda K. Fas-Fas ligand system mediates luteal cell death in bovine corpus luteum. Biol.Reprod. 2002; 66: 754-759.

 

  • 3. Taniguchi H, Uenoyama Y, Miyamoto Y, Okuda K. The lipoxygenase pathways are involved in LH-stimulated progesterone production in bovine corpus luteum. Prostaglandins Other Lipid Mediat. 2002; 67: 49-60.

 

  • 2. Fujiwara C, Murakami S, Taniguchi H, Miyamoto Y, Sakumoto R, Takeuchi S, Takahashi S, Okuda K. Hepatocyte growth factor is a regulator in the proliferation of microvascular endothelial cells in bovine corpus luteum. J Reprod Dev. 2002;48:49-55.

 

  • 1. Okuda K, Uenoyama Y, Berisha B, Lange IG, Taniguchi H, Kobayashi S, Kobayashi S, Miyamoto  A, Schams D. Estradiol-17beta is produced in bovine corpus luteum. Biol.Reprod 2001; 65: 1634-1639. 

bottom of page